Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly

N Engl J Med. 2022 Mar 3;386(9):e29. doi: 10.1056/NEJMe2203035.
No abstract available

Publication types

  • Editorial
  • Interview
  • Webcast

MeSH terms

  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / supply & distribution
  • Clinical Trials as Topic / economics
  • Disaster Planning
  • Drug Approval
  • Genetic Vectors
  • Humans
  • Immunogenicity, Vaccine
  • Public Health Practice*
  • Time Factors
  • Vaccine Development* / economics
  • Vaccine Development* / methods
  • Vaccine Efficacy*
  • Vaccines / supply & distribution*
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines
  • mRNA Vaccines